Therapy: Low-dose aspirin to reduce the risk of pre-eclampsia?

Nature Reviews Endocrinology

Volumn 11, Issue 1, 2015, Pages 6-8

  Sibai, Baha M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADVERSE OUTCOME; ARTICLE; BRAIN HEMORRHAGE; FEMALE; GESTATION PERIOD; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; NEONATAL HEMORRHAGE; PERINATAL PERIOD; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RISK BENEFIT ANALYSIS; RISK REDUCTION; SOLUTIO PLACENTAE; TREATMENT OUTCOME; PRE-ECLAMPSIA; PREGNANCY;

ASPIRIN; FEMALE; HUMANS; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84927176231     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2014.199     Document Type: Article

References (8)

1. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 122, 1122-1131 (2013)
2. Barton, J. R. & Sibai, B. M. Prediction and prevention of recurrent preeclampsia. Obstet. Gynecol. 112, 359-372 (2008)
3. Meher, S. & Alfirevic, Z. Aspirin for pre-eclampsia; beware of subgroup meta-analysis. Ultrasound Obstet. Gynecol. 41, 479-485 (2013)
4. Askie, L. M., Duley, L., Henderson-Smart, D. J., Stewart, L. A. & PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369, 1791-1798 (2007)
5. LeFevre, M. L. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventative Task Force recommendation statement. Ann. Intern. Med. http://dx.doi.org/10.7326/M14-1884.
6. [No authors listed] CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9, 364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 343, 619-629 (1994)
7. [No authors listed] ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevençao da Pré-eclampsia com Aspirina) Collaborative Group. Br. J. Obstet. Gynaecol. 103, 39-47 (1996)
8. Caritis, S. et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child. Health and Human Development Network of Maternal-Fetal Medicine Units. N. Engl. J. Med. 338, 701-705 (1998)